Efficacy of dienogest in the treatment of symptomatic adenomyosis: a pilot study
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Adenomyosis is a common disorder in premenopausal women that causes dysmenorrhea, pelvic pain and menorrhagia. Considering that adenomyosis is an estrogen-dependent disease, the medical treatment is based on this hormone. Effective and well-tolerated medical treatments for symptomatic adenomyosis are needed. Dienogest, an oral progestin, has been extensively investigated in the treatment of endometriosis. In this report, we present the results on the efficacy and safety of dienogest in the treatment of symptomatic adenomyosis. Seventeen patients with symptomatic adenomyosis were included in this study, of which 15 continued dienogest for up to 24 weeks. Dienogest significantly reduced adenomyosis-associated pelvic pain as well as serum CA-125 and CA19-9 levels. It also demonstrated a modest suppression of estradiol (>50 pg/ mL), which is consistent with the findings of other reports. During treatment, five patients experienced worsening anemia because of metrorrhagia, which is the most frequent adverse effect associated with dienogest. This report suggests that dienogest is an effective and well-tolerated therapy for symptomatic adenomyosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Strowitzki, T., Marr, J., Gerlinger, C., Faustmann, T., & Seitz, C. (2010) · Human Reproduction · doi:10.1093/humrep/dep469 · Cited by 381 · cited 2×
“The efficacy of dienogest for endometriosis-associated pelvic pain has been established [3–6,16] and has been shown to be comparable to that of GnRH agonists [3,4].”
BackgroundReduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment
Petraglia, F., Hornung, D., Seitz, C., Faustmann, T., Gerlinger, C., Luisi, S., Lazzeri, L., & Strowitzki, T. (2012) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-011-1941-7 · Cited by 200
Long‐term use of dienogest for the treatment of endometriosis
Momoeda, M., Harada, T., Terakawa, N., Aso, T., Fukunaga, M., Hagino, H., & Taketani, Y. (2009) · Journal of Obstetrics and Gynaecology Research · doi:10.1111/j.1447-0756.2009.01076.x · Cited by 192
MR imaging of diffuse adenomyosis changes after GnRH analog therapy
Imaoka, I., Ascher, S. M., Sugimura, K., Takahashi, K., Li, H., Cuomo, F., Simon, J., & Arnold, L. L. (2002) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10060 · Cited by 72
Dienogest, a new conservative strategy for extragenital endometriosis: a pilot study
Harada, M., Osuga, Y., Izumi, G., Takamura, M., Takemura, Y., Hirata, T., Yoshino, O., Koga, K., Yano, T., & Taketani, Y. (2011) · Gynecological Endocrinology · doi:10.3109/09513590.2010.533800 · Cited by 43
Self-citation
Cited by
Role of medical therapy in the management of uterine adenomyosis
Vannuccini, S., Luisi, S., Tosti, C., Sorbi, F., & Petraglia, F. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.01.013 · Cited by 231
Morotti, M., Sozzi, F., Remorgida, V., Venturini, P. L., & Ferrero, S. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2014.10.036 · Cited by 84
Conservative management of uterine adenomyosis: medical vs. surgical approach
Stratopoulou, C. A., Donnez, J., & Dolmans, M.-M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10214878 · Cited by 62
“However, a pilot study in 15 patients receiving dienogest for 24 weeks failed to demonstrate significant reduction in either uterine or lesion size or the width of the junctional zone, though pain relief levels were acceptable [16].”
Background
Metadata
- Authors
- Hirata, T., Izumi, G., Takamura, M., Saito, A., Nakazawa, A., Harada, M., Hirota, Y., Koga, K., Fujii, T., & Osuga, Y.
- Venue
- Gynecological Endocrinology
- Publisher
- Informa UK Limited
- Published
- 2014-06-06
- Volume
- 30
- Issue
- 10
- Pages
- 726-729
- ISSN
- 0951-3590 (ISSN-L)
- 1473-0766
- OpenAlex
- W1988101865
- Cited by
- 65
- References
- 5
- FWCI
- 3.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy of dienogest in the treatment of symptomatic adenomyosis: a pilot study. https://app.cochat.ai/papers/10.3109/09513590.2014.926882
- The paper
- Hirata, T., Izumi, G., Takamura, M., Saito, A., Nakazawa, A., Harada, M., Hirota, Y., Koga, K., Fujii, T., & Osuga, Y. (2014). Efficacy of dienogest in the treatment of symptomatic adenomyosis: a pilot study. Gynecological Endocrinology. https://doi.org/10.3109/09513590.2014.926882
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.